GSK3B and glaucoma: Research indicates that cannabinoids influence several pathways related to glaucoma: Endocannabinoid System (ECS) [58], WNT/β-Catenin Pathway [59], and Glycogen synthase kinase-3 beta (GSK-3β) Signaling [59].